Actively Recruiting
Empowering Narratives
Led by Kristiania University College · Updated on 2025-08-17
50
Participants Needed
1
Research Sites
59 weeks
Total Duration
On this page
Sponsors
K
Kristiania University College
Lead Sponsor
U
University of Konstanz
Collaborating Sponsor
AI-Summary
What this Trial Is About
Background: The Russian invasion of Ukraine has resulted in forced displacement, with over 80,000 Ukrainian refugees now residing in Norway. This displacement has led to increased vulnerability to trauma and mental health challenges. Narrative Exposure Therapy (NET), a short-term trauma-focused intervention, has demonstrated efficacy in reducing PTSD symptoms among individuals exposed to organized violence and war. Aim: The protocol aims to assess the clinical effects of Narrative Exposure Therapy (NET) on PTSD and depression symptoms among Ukrainian refugees in Norway and to facilitate training and supervised practice for Ukrainian health professionals and workers in using NET. Methods: This study employs a pretest-posttest randomized controlled experimental design. Ukrainian health professionals and workers in Norway will receive standardized NET training through a digital course. Subsequently, they will treat Ukrainian refugees using NET under supervision. Participants will be screened and assessed at three time points: baseline, immediately after treatment, and at 6-month follow-up. Validated questionnaires in Ukrainian and Russian will be used: PHQ-9, ITQ, LEC-5, SHUT-D, and demographic questionnaire. Exclusion criteria include active psychotic spectrum disorders, neurodevelopmental disorders and concurrent trauma therapy.
CONDITIONS
Official Title
Empowering Narratives
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ukrainian refugee residing in Norway
- Arrival in Norway after 24 February 2022
- Minimum 18 years old
- Provided informed consent for participation
- Classified as having PTSD symptoms (ITQ) OR reported traumatic experience (LEC-5) OR present PTSD comorbidities (PHQ-9, Shut-D)
You will not qualify if you...
- Diagnosis, history, or scores compatible with the psychotic spectrum
- Diagnostic of neurodevelopmental disorders
- Current participation in ongoing trauma-focused psychological treatment (e.g., therapy for PTSD)
- Declining consent for mandatory elements of the study (e.g., participation in screening or treatment delivery)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kristinia University of Applied Sciences
Oslo, Norway, 0187
Actively Recruiting
Research Team
V
Vanessa Nolasco Ferreira, Associate Professor, PhD
CONTACT
A
Ashley Rebecca Bell-Mizori, Master in Psychology
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here